reports
PTC Inc: 2 directors
Two Directors at PTC Inc sold 5,432 shares at between 174.807USD and 175.362USD. The significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
- Jonathan Moreland
RF REGIONS FINANCIAL CORPORATION
NEOG NEOGEN CORPORATION
LGND LIGAND PHARMACEUTICALS INCORPORATED
INTC INTEL CORPORATION
HXL HEXCEL CORPORATION
FFIN FIRST FINANCIAL BANKSHARES INC
EGBN EAGLE BANCORP INC.
DLTR DOLLAR TREE INC.
CINF CINCINNATI FINANCIAL CORPORATION
CHDN CHURCHILL DOWNS INCORPORATED
SWKS SKYWORKS SOLUTIONS INC.
HTLD HEARTLAND EXPRESS INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
CET CENTRAL SECURITIES CORP.
LIND LINDBLAD EXPEDITIONS HOLDINGS
WDFC WD-40 COMPANY
FEIM FREQUENCY ELECTRONICS INC.
AINC ASHFORD
CLF CLIFFS NATURAL RESOURCES INC.
PWOD PENNS WOODS BANCORP INC.
ATOM ATOMERA
LOVE LOVESAC
FVCB FVCBANKCORP
INMB INMUNE BIO
MCFT INC.
CAPR MASTERCRAFT BOAT HOLDINGS
RYES CAPRICOR THERAPEUTICS
HQL PATRIOT MINEFINDERS INC.
SOWG TEKLA LIFE SCIENCES INVESTORS
CPZ SOW GOOD INC.
AUID CALAMOS LONG/SHORT EQUITY AND DYNAMIC INCOME TRUST
JBHT IPSIDY INC.
TBBK J.B. HUNT TRANSPORT SERVICES
MPA INC.
FTHY THE BANCORP
AIKI INC.
BHVN BLACKROCK MUNIYIELD PENNSYLVANIA FD
BUKS FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
ACRV AIKIDO PHARMA INC.
ZURA BIOHAVEN LTD
ABEO BUTLER NATIONAL CORP
STCN ACRIVON THERAPEUTICS INC
KRRO ZURA BIO LTD
LSXMA ABEONA THERAPEUTICS INC.
EP STEEL CONNECT INC
INTZ KORRO BIO INC
LGVN LIBERTY SIRIUSXM GROUP
OCX EMPIRE PETROLEUM CORP
EYPT INTRUSION INC
IZEA LONGEVERON INC
CFFI ONCOCYTE CORPORATION
EYEPOINT PHARMACEUTICALS
INC.
IZEA WORLDWIDE INC
C&F FINANCIAL CORPORATION
Ansys Announces Q1 Financial Results
Ansys Announces Q1 Financial Results / Q1 2024 Results Revenue of $466.6 millionGAAP diluted earnings per share of $0.40 and non-GAAP diluted earnings per share of $1.39GAAP operating profit margin of 9.3% and non-GAAP operating profit margin of 32.2%Operating cash flows of $282.8 million and unlevered operating cash flows of $292.7 millionAnnual Contract Value (ACV) of $407.4 millionDeferred revenue and backlog of $1,369.5 million on March 31, 2024 PITTSBURGH, May 01, 2024 (GLOBE NEWSWIRE) -- ANSYS, Inc. (NASDAQ: ANSS), today reported first quarter 2024 revenue of $466.6 million, a ...
- Guy Sips
Materialise Medical segment continued to lead the way
We updated our Materialise model after 1Q24 revenues decreased 3% y/y as 1Q23 was an exceptionally strong quarter showing 24% growth. In 1Q24, Materialise's Medical segment continued to lead the way with 8% y/y revenue growth, while revenue declined in its Manufacturing and Software segments amidst less favourable market conditions. While continued investments in sustainable growth and the ongoing conversion to a recurring revenue business model impacted Materialise's operational profitability,...
- Guy Sips
- Hilde Van Boxstael
- Lynn Hautekeete
- Michiel Declercq
- Thibault Leneeuw
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
- Jonathan Moreland
MHLD MAIDEN HOLDINGS LTD.
HNRG HALLADOR ENERGY CO.
HOO HERBALIFE NUTRITION LTD.
DLTR DOLLAR TREE INC.
CRK COMSTOCK RESOURCES INC.
LULU LULULEMON ATHLETICA INC
RAIL FREIGHTCAR AMERICA INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
GLQ CLOUGH GLOBAL EQUITY FUND
WDFC WD-40 COMPANY
AINC ASHFORD
BRT BRT APARTMENTS
ISDR ISSUER DIRECT CORP.
LOVE LOVESAC
CWEN CLEARWAY ENERGY INC. CLASS C
ORGO ORGANOGENESIS HOLDINGS (A)
HROW HARROW HEALTH INC.
LEGH LEGACY HOUSING CORP
REEMF RARE ELEMENT RESOURCES
AIM AIM IMMUNOTECH
DCTH DELCATH SYSTEMS
HGBL HERITAGE GLOBAL
NKTX NKARTA
EGLE EAGLE BULK SHIPPING
SOWG SOW GOOD INC.
PHX PANHANDLE OIL AND GAS INC
SMMT SUMMIT THERAPEUTICS INC
AUID IPSIDY INC.
FSBC FIVE STAR BANCORP
DERM JOURNEY MEDICAL CORP
LEE LEE ENTERPRISES INC
MPA BLACKROCK MUNIYIELD PENNSYLVANIA FD
FTHY FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
TCBX THIRD COAST BANCSHARES INC
ASLE AERSALE CORP
AIKI AIKIDO PHARMA INC.
BUKS BUTLER NATIONAL CORP
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
NMAI NUVEEN MULTI-ASSET INCOME FUND
ACRV ACRIVON THERAPEUTICS INC
LSXMA LIBERTY SIRIUSXM GROUP
TISI TEAM INC.
CBSTF CANNABIST CO HOLDINGS INC.
TSVT 2SEVENTY BIO INC
ASGI ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
INTZ INTRUSION INC
PROP PRAIRIE OPERATING CO.
LGVN LONGEVERON INC
OCX ONCOCYTE CORPORATION
- Jonathan Moreland
3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK C...
3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants FDA clearance enables wide-spread adoption of 3D Systems self-contained, cleanroom environment-based printing system, the EXT 220 MED, with medical-grade PEEK materials to deliver patient-specific cranial reconstruction solutions3D-printed PEEK implants using the EXT 220 MED successfully demonstrated in nearly 40 cranioplasties across Europe in recent monthsMarket for cranial reconstruction anticipated to exceed $2 billion by 2030FDA clearance establishes strong foundation for expanded application of thes...
- Jonathan Moreland
NEOG NEOGEN CORPORATION
MHLD MAIDEN HOLDINGS LTD.
HNRG HALLADOR ENERGY CO.
HOO HERBALIFE NUTRITION LTD.
GOGO GOGO INC.
DLTR DOLLAR TREE INC.
CRK COMSTOCK RESOURCES INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
LULU LULULEMON ATHLETICA INC
AAOI APPLIED OPTOELECTRONICS INC.
RAIL FREIGHTCAR AMERICA INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
GLQ CLOUGH GLOBAL EQUITY FUND
BRT BRT APARTMENTS
VICI VICI PROPERTIES INC
STKS THE ONE GROUP HOSPITALITY INC.
ISDR ISSUER DIRECT CORP.
CWEN CLEARWAY ENERGY INC. CLASS C
ORGO ORGANOGENESIS HOLDINGS (A)
HROW HARROW HEALTH INC.
LEGH LEGACY HOUSING CORP
REEMF RARE ELEMENT RESOURCES
AIM AIM IMMUNOTECH
DCTH DELCATH SYSTEMS
HGBL HERITAGE GLOBAL
NKTX NKARTA
EGLE EAGLE BULK SHIPPING
SOWG SOW GOOD INC.
PHX PANHANDLE OIL AND GAS INC
SMMT SUMMIT THERAPEUTICS INC
FSBC FIVE STAR BANCORP
DERM JOURNEY MEDICAL CORP
LEE LEE ENTERPRISES INC
ACHR ARCHER AVIATION INC
FTHY FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
TCBX THIRD COAST BANCSHARES INC
ASLE AERSALE CORP
AIKI AIKIDO PHARMA INC.
BUKS BUTLER NATIONAL CORP
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
NMAI NUVEEN MULTI-ASSET INCOME FUND
LSXMA LIBERTY SIRIUSXM GROUP
TISI TEAM INC.
CBSTF CANNABIST CO HOLDINGS INC.
TSVT 2SEVENTY BIO INC
ASGI ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
INTZ INTRUSION INC
PROP PRAIRIE OPERATING CO.
LGVN LONGEVERON INC
- Jonathan Moreland
- Jonathan Moreland
Synopsys Inc: 1 director
A director at Synopsys Inc sold/sold after exercising options 5,319 shares at 579.369USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing
3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing ROCK HILL, South Carolina, March 22, 2024 (GLOBE NEWSWIRE) -- (NYSE:DDD) (“the Company”) today announced that, on March 18, 2024, it received a notice (the “NYSE Notice”) from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria established in Section 802.01E of the NYSE Listed Company Manual, because the Company has not timely filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10...
Wilting Expands Production Capacity with Three DMP Flex 350 Printers
Wilting Expands Production Capacity with Three DMP Flex 350 Printers Addition of single and dual laser printers enables use of broader materials portfolio to address new applications with Titanium, Stainless SteelDMP Flex 350’s best-in-class oxygen level (
3D Systems Announces Additional Partial Repurchase of Convertible Seni...
3D Systems Announces Additional Partial Repurchase of Convertible Senior Notes Repurchasing approximately $110 million of 0% coupon, convertible senior notes at approximately 22% discount to par value Reduces remaining balance of outstanding notes to approximately $214 million, over 50% reduction from initial issued principal balance of $460 million, due 2026Reinforces balance sheet strength and maintains strong cash position to support operational needs ROCK HILL, S.C., March 05, 2024 (GLOBE NEWSWIRE) -- (NYSE:DDD) (“the Company”) today announced that it has entered into separate, pr...
3D Systems Reports Fourth Quarter and Full Year 2023 Financial Results...
3D Systems Reports Fourth Quarter and Full Year 2023 Financial Results (Unaudited) ROCK HILL, S.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter Financial Results (Unaudited)(All numbers are unaudited and are presented in thousands, except per share amounts or otherwise noted) Q4 2023 revenue of $114,848 decreased 13.5% compared to Q4 2022 due to significant softness in dental orthodontics and depressed printer sales from delayed customer capex investmentsQ4 2023 gross pro...
QuidelOrtho Corp: 1 director
A director at QuidelOrtho Corp bought 2,150 shares at 46.355USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- Guy Sips
Materialise Model update after FY23 results
Materialise expect sales in all three of its segments to increase. The growth of its Materialise Software revenue will be further temporarily impacted by the transition towards a cloud-based subscription business model that Materialise is continuing to implement. We updated our model as, based on current market conditions, Materialise expects FY24 revenues to grow to a range of € 265m to € 275m (KBCSe from € 291.6m to € 271.6m). This expected revenue growth will result in FY24 Adj. EBIT forecast...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.